Autor Título Original / Colaboración Selecciona una opción Original Colaboración Año Selecciona un año20152016201720182019202020212022202320242025 Cuartil Selecciona un cuartilD1Q1Q2Q3Q4 Tipo Selecciona un tipo#N/DArticleArtículoBook ChapterBook ReviewClinical TrialCommentaryCorrectionData PaperEditorialEditorial MaterialExpression of ConcernLetterProceedings PaperReprintReview Revista Validation of the Spanish version of the EORTC QLQ-CML24 questionnaire for assessment of health-related quality of life in patients with chronic myeloid leukemia (vol. 104, pg. 3693, 2025) Autores: Lopez-Fernández, E; de Linares-Fernández, S; Perez-Marfil, MN; Vera-Goñi, JA; Anguita-Arance, M; Fernández-Valle, MD; Ramírez-Sánchez, MJ; Ruiz-Nuño, MC; González-Molina, W; Ferrer-Chaves, C; Avellaneda-Molina, C; Puerta-Puerta, JM Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC Autores: Escamilla-Gómez, V; Gutiérrez, VG; Alcalde-Mellado, P; Astibia-Mahillo, B; Chinea-Rodriguez, A; López-Corral, L; Acera-Gómez, M; Ochando, MKT; Borrego, AB; Pinedo, LG; Ripa, TZ; Vicent, MG; Benzaquén, A; García, II; Cantó, PA; Montoro, J; Martín-Domínguez, FM; Orti, G; Valcárcel, D; Benitez-Carabante, MI; Diaz-de-Heredia, C; Cañamero, E; Ferrá, C; García-Cadenas, I; Redondo, S; Sisinni, L; Perez-Martínez, A; Mussetti, A; Garcia-Mañó, L; Palomo-Moraleda, MD; González-Sierra, PA; Jurado, M; Perez-Simon, JA; GETH-TC Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation Autores: Torrent-Rodríguez, A; Cascos, E; Garcés, VN; Pérez-López, E; Baile-González, M; Rodríguez, CM; Cascón, MJP; Luque, M; Esquirol, A; Calvo, CM; Peña-Muñoz, F; Fernando, IH; Ormtegi, IO; Marín, AJS; Fernández-Luis, S; Domínguez-García, JJ; Fernández, SV; Lorenzo, JLL; Girón, MFD; Pinedo, LG; García-Maño, L; González-Rodriguez, AP; Torrado, T; Filaferro, S; Basalobre, P; Ortí, G; Rovira, M; Chacón, MJ; Salas, MQ Risk and Benefit Assessment of Gene Therapy with Lentiviral Vectors and Hematopoietic Stem Cells: The Skysona Case Autores: Puig-Serra, P; Hinckley-Boned, A; Tristán-Manzano, M; Rio, P; Torres-Ruiz, R; Rodriguez-Perales, S; Martín, F Exploring miR-21 Knock-Out Using CRISPR/Cas as a Treatment for Lung Cancer Autores: Lara, P; Aguilar-González, A; Martín, F; Mesas, C; Moreno, J; Rama, AR Regulatory Strategies for Accelerating the Translation of Gene Therapies to Clinical Practice: Focus on GMO Considerations Autores: Delgadillo, J; Martin, F; Carmona, G; Canals, JM; Rio, P; Eguizabal, C; Prosper, F; Avendaño-Solá, C Donor insertion into CX3CR1 allows epigenetic modulation of a constitutive promoter on hematopoietic stem cells and its activation upon myeloid differentiation Autores: Ramos-Hernández, I; Fuster-García, C; Aguilar-González, A; Lozano-Vinagre, ML; Guenechea-Amurrio, G; Sanchez-Luque, FJ; Gonçalves, MAF; Cathomen, T; Muñoz, P; Molina-Estévez, FJ; Martín, F < 1 2 … 15 16 17 … 1.706 1.707 >